StockTipsArenaBeta

Aurobindo PharmaShare price targets & analyst calls

Sector:Pharmaceuticals & Biotechnology
₹1,653.1+15.80 (+0.97%)
As of 4 Sept 2026
Analysts lean BUY·9 of 10 long-term calls BUY·consensus 1Y target ₹1,706 (3.2% above CMP)
₹1,706
3.2% above CMP
₹950 – ₹1,900
10 active 1Y targets
13 open
11 BUY · 2 SELL (all horizons)
49%
36 of 74 closed calls hit
Watch AUROPHARMA for new buy/sell callsGet alertsSee 52 Pharmaceuticals & Biotechnology sector analyst picks

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

All tips (89) · loading…

BUYAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)
AI11+·6−-0.9% P&L+8.9% upside left
₹1,653.1
CMP
Entry*
₹1,668
Target
₹1,800
MOMotilal Oswal· via CNBC Awaaz.4w ago
BUYAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)
AI11+·6−+1.7% P&L+8.9% upside left
₹1,653.1
CMP
Entry*
₹1,625.4
Target
₹1,800
CCitigroup· via CNBC Awaaz.4w ago
BUYAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)
AI11+·6−+4.6% P&L0.0% upside left
₹1,653.1
CMP
Entry*
₹1,580.1
Target
₹1,600
CClsa· via CNBC Awaaz.4w ago
BUYAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)
AI11+·6−+4.6% P&L+14.9% upside left
₹1,653.1
CMP
Entry*
₹1,580.1
Target
₹1,900
HSHSBC Securities· via CNBC Awaaz.4w ago
BUYAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)
AI11+·6−+4.6% P&L+5.9% upside left
₹1,653.1
CMP
Entry*
₹1,580.1
Target
₹1,750
GSGoldman Sachs· via CNBC Awaaz.4w ago
BUYAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)
AI11+·6−+4.0% P&L+12.5% upside left
₹1,653.1
CMP
Entry*
₹1,588.9
Target
₹1,860
MOMotilal Oswal· via Institutional / Brokerage Research4w ago
BUYAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)
AI11+·6−+1.7% P&L+11.9% upside left
₹1,653.1
CMP
Entry*
₹1,625
Target
₹1,850
GSGoldman Sachs· via ET Now (Live)4w ago
SELLAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)
AI5+·11−-7.8% P&L+42.5% upside left
₹1,653.1
CMP
Target
₹950
Entry*
₹1,533.5
EGEmkay Global· via ET Now (Live)5w ago
BUYAUROPHARMAAurobindo Pharma1 Year
AI11+·6−+6.7% P&L+8.9% upside left
₹1,653.1
CMP
Entry
₹1,550
Target
₹1,800
ABAshish Bahety, Profitmart Securities· via CNBC Awaaz.8w ago
BUYAUROPHARMAAurobindo Pharma1 Year
AI11+·6−+8.0% P&L+5.9% upside left
₹1,653.1
CMP
Entry
₹1,530
Target
₹1,750
ABAshish Bahety, Profitmart Securities· via CNBC Awaaz.8w ago
BUYAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+11.91% realised0.0% upside left
Entry*
₹1,342.1
Target
₹1,502
hit 8 May 2026, 12:05 pm
GFGeojit Financial Services· via Institutional / Brokerage Research22w ago
BUYAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+17.31% realised0.0% upside left
Entry*
₹1,278.7
Target
₹1,500
hit 8 May 2026, 12:05 pm
MOMotilal Oswal· via Institutional / Brokerage Research23w ago
BUYAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+24.39% realised0.0% upside left
Entry*
₹1,145.6
Target
₹1,425
hit 22 Apr 2026, 12:04 pm
ISICICI Securities· via Institutional / Brokerage Research29w ago
BUYAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+17.30% realised0.0% upside left
Entry*
₹1,146.6
Target
₹1,345
hit 1 Apr 2026, 12:04 pm
ASAxis Securities· via Institutional / Brokerage Research29w ago
BUYAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+15.11% realised0.0% upside left
Entry*
₹1,124.1
Target
₹1,294
hit 11 Mar 2026, 12:03 pm
BCBOB Capital Markets· via Institutional / Brokerage Research29w ago
BUYAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+21.33% realised0.0% upside left
Entry*
₹1,145.6
Target
₹1,390
hit 17 Apr 2026, 12:04 pm
MOMotilal Oswal· via Institutional / Brokerage Research29w ago
BUYAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+24.28% realised0.0% upside left
Entry*
₹1,150.6
Target
₹1,430
hit 23 Apr 2026, 12:04 pm
MOMotilal Oswal· via Institutional / Brokerage Research31w ago
BUYAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+18.29% realised0.0% upside left
Entry*
₹1,208.9
Target
₹1,430
hit 23 Apr 2026, 12:04 pm
MOMotilal Oswal· via Institutional / Brokerage Research39w ago
BUYAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+19.07% realised0.0% upside left
Entry*
₹1,154.8
Target
₹1,375
hit 15 Apr 2026, 12:04 pm
ISICICI Securities· via Institutional / Brokerage Research42w ago
BUYAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+20.13% realised0.0% upside left
Entry*
₹1,123.8
Target
₹1,350
hit 1 Apr 2026, 12:04 pm
ISICICI Securities· via Institutional / Brokerage Research43w ago
BUYAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+19.68% realised0.0% upside left
Entry*
₹1,123.8
Target
₹1,345
hit 1 Apr 2026, 12:04 pm
ASAxis Securities· via Institutional / Brokerage Research43w ago
BUYAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+15.38% realised0.0% upside left
Entry*
₹1,140.6
Target
₹1,316
hit 11 Mar 2026, 12:03 pm
BCBOB Capital Markets· via Institutional / Brokerage Research43w ago
BUYAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+18.36% realised0.0% upside left
Entry*
₹1,140.6
Target
₹1,350
hit 1 Apr 2026, 12:04 pm
MOMotilal Oswal· via Institutional / Brokerage Research43w ago
BUYAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+21.23% realised0.0% upside left
Entry*
₹1,072.3
Target
₹1,300
hit 11 Mar 2026, 12:03 pm
PLPrabhudas Lilladher· via Institutional / Brokerage Research56w ago
BUYAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+29.71% realised0.0% upside left
Entry*
₹1,079.3
Target
₹1,400
hit 21 Apr 2026, 12:04 pm
ASAxis Securities· via Institutional / Brokerage Research56w ago
BUYAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+20.45% realised0.0% upside left
Entry*
₹1,079.3
Target
₹1,300
hit 11 Mar 2026, 12:03 pm
MOMotilal Oswal· via Institutional / Brokerage Research56w ago
BUYAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+15.91% realised0.0% upside left
Entry*
₹1,079.3
Target
₹1,251
hit 7 Jan 2026, 12:01 pm
BCBOB Capital Markets· via Institutional / Brokerage Research56w ago
BUYAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+13.15% realised0.0% upside left
Entry*
₹1,191.3
Target
₹1,348
hit 1 Apr 2026, 12:04 pm
GFGeojit Financial Services· via Institutional / Brokerage Research61w ago
BUYAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+30.68% realised0.0% upside left
Entry*
₹1,147.8
Target
₹1,500
hit 8 May 2026, 12:05 pm
ASAxis Securities· via Institutional / Brokerage Research66w ago
BUYAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+20.89% realised0.0% upside left
Entry*
₹1,191.2
Target
₹1,440
hit 23 Apr 2026, 12:00 am
PLPrabhudas Lilladher· via Institutional / Brokerage Research66w ago
BUYAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
AI1+·0−+20.80% realised0.0% upside left
Entry*
₹1,221
Target
₹1,475
hit 8 Aug 2024, 12:08 pm
ISICICI Securities· via Institutional / Brokerage Research118w ago
BUYAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
AI1+·0−+8.63% realised0.0% upside left
Entry*
₹1,090.9
Target
₹1,185
hit 13 May 2024, 12:05 pm
ASAxis Securities· via Institutional / Brokerage Research130w ago
BUYAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
AI1+·0−+13.02% realised0.0% upside left
Entry*
₹1,026.4
Target
₹1,160
hit 30 Apr 2024, 12:04 pm
ASAxis Securities· via Institutional / Brokerage Research133w ago
BUYAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Expired
+15.68% realisedNA upside left
₹1,286
At expiry
Entry*
₹1,111.7
Target
₹1,451
expired 17 Mar 2026, 3:30 pm
BCBOB Capital Markets· via Institutional / Brokerage Research76w ago
BUYAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Expired
-4.51% realisedNA upside left
₹1,124.1
At expiry
Entry*
₹1,177.15
Target
₹1,510
expired 10 Feb 2026, 3:30 pm
PLPrabhudas Lilladher· via Institutional / Brokerage Research81w ago
BUYAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Expired
-4.51% realisedNA upside left
₹1,124.1
At expiry
Entry*
₹1,177.15
Target
₹1,500
expired 10 Feb 2026, 3:30 pm
ASAxis Securities· via Institutional / Brokerage Research81w ago
BUYAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Expired
-0.06% realisedNA upside left
₹1,191
At expiry
Entry*
₹1,191.7
Target
₹1,445
expired 6 Feb 2026, 3:30 pm
ISICICI Securities· via Institutional / Brokerage Research82w ago
BUYAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Expired
+1.01% realisedNA upside left
₹1,235.8
At expiry
Entry*
₹1,223.4
Target
₹1,540
expired 27 Nov 2025, 3:30 pm
GFGeojit Financial Services· via Institutional / Brokerage Research92w ago
BUYAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Expired
AI1+·0−-1.14% realisedNA upside left
₹1,235.8
At expiry
Entry*
₹1,250.1
Target
₹1,580
expired 19 Nov 2025, 3:30 pm
ISICICI Securities· via Institutional / Brokerage Research93w ago
BUYAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Expired
AI1+·0−-6.61% realisedNA upside left
₹1,183.6
At expiry
Entry*
₹1,267.4
Target
₹1,460
expired 12 Nov 2025, 3:30 pm
ASAxis Securities· via Institutional / Brokerage Research94w ago
BUYAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Expired
AI1+·0−-9.38% realisedNA upside left
₹1,168.2
At expiry
Entry*
₹1,289.05
Target
₹1,532
expired 11 Nov 2025, 3:30 pm
SRSharekhan Research· via Institutional / Brokerage Research94w ago
BUYAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Expired
AI1+·0−-28.40% realisedNA upside left
₹1,078.2
At expiry
Entry*
₹1,505.8
Target
₹1,785
expired 13 Aug 2025, 3:30 pm
ISICICI Securities· via Institutional / Brokerage Research107w ago
BUYAUROPHARMAAurobindo Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Expired
AI1+·0−-28.40% realisedNA upside left
₹1,078.2
At expiry
Entry*
₹1,505.8
Target
₹1,612
expired 13 Aug 2025, 3:30 pm
ASAxis Securities· via Institutional / Brokerage Research107w ago
SELLAUROPHARMAAurobindo Pharma1–3 Months
AI6+·10−-1.7% P&L+21.4% upside left
₹1,653.1
CMP
Target
₹1,300
Entry*
₹1,625
MMacquarie· via CNBC Awaaz.4w ago
BUYAUROPHARMAAurobindo Pharma1–3 MonthsTarget hit
AI16+·7−+6.25% realised0.0% upside left
Entry
₹1,600
Target
₹1,700
hit 31 Aug 2026, 12:08 pm
SHSwati Hotkar, Nirmal Bang Securities· via NDTV Profit2w ago
BUYAUROPHARMAAurobindo Pharma1–3 MonthsTarget hit
+5.49% realised0.0% upside left
Entry
₹1,497.8
Target
₹1,580
hit 29 Jun 2026, 12:06 pm
HSHSBC Securities· via NDTV Profit (Live)10w ago
BUYAUROPHARMAAurobindo Pharma1–3 Months* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
AI4+·3−-0.75% realisedNA upside left
SL
₹1,545
Entry*
₹1,556.7
Target
₹1,680
hit 3 Aug 2026, 12:08 pm
AKAshish Kyal, Waves Strategy Advisors· via CNBC Awaaz.5w ago
BUYAUROPHARMAAurobindo Pharma1–3 MonthsExpired○ No trade
— realisedNA upside left
SL
₹1,250
Entry
₹1,280
Target
₹1,500
AMAjit Mishra, Religare· via ET Now21w ago
BUYAUROPHARMAAurobindo Pharma1–3 MonthsExpired
+15.90% realisedNA upside left
₹1,552.6
At expiry
Entry*
₹1,339.6
Target
₹1,600
expired 1 Jul 2026, 3:30 pm
SHSwati Hotkar, Nirmal Bang Securities· via NDTV Profit22w ago
BUYAUROPHARMAAurobindo Pharma1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)
AI6+·4−-0.7% P&L+10.1% upside left
₹1,653.1
CMP
Entry
₹1,665
Target
₹1,820
CTChandan Taparia, Motilal Oswal· via LiveMint Buy-or-Sell (topic)5d ago
StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.